NgBR was demonstrated to be a specific negative regulator for hepatic lipogenesis, which is apparently inconsistent with the positive regulatory role of Nogo‐B during liver fibrosis/cirrhosis (Hu et al., 2016). The gene discussed is NUS1; the disease is Cirrhosis.